PEN today
$320.98-$0.74 (-0.23%)close Nov 12, 2026Trend
DailyUptrend (confirmed)
4 hourLeaning Bearish
1 hourBearish
15 minLeaning Bullish
5 minConsolidating
Daily trend turns down below $302.19
Key levels
Resistance$328.11
Resistance$324.76
Support$319.33
Support$316.35
Latest news & SEC filings
NewsPanoro Energy reports helium and methane resource potential at South Africa onshore site
EarningsPenumbra Releases Q3 2026 Financial Results
EarningsPenumbra's Quarterly Profit Falls Short of Analyst View, Revenue Tops Forecast
SEC FilingPenumbra Inc filed a report on a major company event (Form 8-K)
All PEN news →About Penumbra
Penumbra makes medical devices that clear blood clots and treat vascular disease. Its offerings include clot-removal systems for ischemic stroke, pulmonary embolism, and acute limb ischemia, plus embolization and access tools for aneurysms and related conditions. The company sells directly in the United States, much of Europe, Canada, Australia, and Singapore, and via distributors elsewhere. Its buyers are doctors and clinicians who perform these procedures.
Based on the company's 10-K filed Feb 25, 2026.
NYSE · Healthcare
Penumbra Inc (PEN)
What Is the Price Target for PEN?
SEPT Low Target
$335.00
SEPT Mid Target
$342.50
SEPT High Target
$350.00
Analyst Consensus
$342.50
Is PEN a Buy or Sell Right Now?
Thesis
- •Revenue growing 17.5% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for PEN.
Start Free Trial →Is PEN Overvalued or Undervalued?
Valuation Verdict
FAIR
Methods Used
P/E Forward, P/B, PEG, Analyst Consensus
Fair Value
$331.37
61
Moat Score
NARROW
7/9
Piotroski Score
21.0
Altman Z-Score
What Is Smart Money Doing with PEN?
Insider Signal
NEUTRAL
0 buys / 3 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
ACCUMULATING
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Narayan Shruthi | officer | Sale | 1,367 | $439K | Oct 15, 2026 |
| Elsesser Adam | director officer | Sale | 77,000 | - | May 19, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →PEN Growth Story
Revenue YoY
17.5%
3yr Revenue CAGR
18.3%
EPS Growth YoY
1155.56%
FCF Growth YoY
18.8%
Revenue Trend
STRONG
Dark Pool Trades for PEN
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for PEN, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 16:11:50 | $320.56 | 1,000 | $$321K | BUY |
| 16:11:44 | $320.57 | 1,000 | $$321K | BUY |
| 16:11:36 | $320.57 | 1,000 | $$321K | BUY |
| 15:35:14 | $320.86 | 1,000 | $$321K | BUY |
| 15:16:01 | $320.55 | 1,000 | $$321K | BUY |
5 dark pool trades shown · $$1.6M preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for PEN
PREVIEWSEPT Investing provides real-time options flow tracking for PEN, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| PUT | $380 | Jan 15 | 64 | $$70.0K | 5 | FLOOR |
| PUT | $300 | Jan 15 | 64 | $$85.0K | 10 | FLOOR |
| PUT | $320 | Apr 16 | 155 | $$66.5K | 5 | FLOOR |
3 options trades shown · 0% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Penumbra Inc (PEN) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (4 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →PEN — frequently asked questions
What is PEN stock price today?
Penumbra Inc (PEN) is at $320.98, down 0.23% (-$0.74) at the Nov 12, 2026 close.
Why is PEN stock moving today?
Latest PEN news — Nov 10, 2026: Panoro Energy reports helium and methane resource potential at South Africa onshore site · Oct 29, 2026: Penumbra Releases Q3 2026 Financial Results
What is the PEN price target?
The average analyst price target for PEN is $342.50, ranging from $335 to $350, based on 2 analysts. Latest: Citigroup maintains on May 7, 2026.
What do analysts rate PEN?
Analyst ratings for PEN: 0 Buy, 2 Hold, 0 Sell — consensus Hold.
Did PEN beat earnings?
PEN last reported on Oct 29, 2026: EPS $1.07 vs $1.25 expected — a miss of 14.4%.
What is PEN's P/E ratio?
PEN trades at a P/E of 80.3 vs a Healthcare average of 18.4.
Does PEN pay a dividend?
PEN does not currently pay a dividend.
What are PEN support and resistance levels?
Support: $319.33, $316.35, $307.00. Resistance: $324.76, $328.11, $335.20.
What are insiders doing with PEN?
Insider activity: NEUTRAL, 0 buys and 3 sells in the last 90 days.
What is the latest news on PEN?
Nov 10, 2026: Panoro Energy reports helium and methane resource potential at South Africa onshore site · Oct 29, 2026: Penumbra Releases Q3 2026 Financial Results · Oct 29, 2026: Penumbra's Quarterly Profit Falls Short of Analyst View, Revenue Tops Forecast